Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging.
about
Quantitative proton MR techniques for measuring fatHeterogeneity of muscle fat infiltration in children with spina bifida.Running-induced patellofemoral pain fluctuates with changes in patella water content.Multisite, multivendor validation of the accuracy and reproducibility of proton-density fat-fraction quantification at 1.5T and 3T using a fat-water phantom.The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes.Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency.Is MR spectroscopy really the best MR-based method for the evaluation of fatty liver in diabetic patients in clinical practice?Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children.Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease.Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adultsAccuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as referenceEvidence and recommendations for imaging liver fat in children, based on systematic review.Interexamination repeatability and spatial heterogeneity of liver iron and fat quantification using MRI-based multistep adaptive fitting algorithm.Quantification of renal steatosis in type II diabetes mellitus using dixon-based MRI.Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes.Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis.Randomized double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 2 diabetes: IMAGINE 4.Agreement between region-of-interest- and parametric map-based hepatic proton density fat fraction estimation in adults with chronic liver disease.The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro.Quantitative magnetic resonance imaging phantoms: A review and the need for a system phantom.Fat fraction mapping using magnetic resonance imaging: insight into pathophysiology.Effect of gadolinium on hepatic fat quantification using multi-echo reconstruction technique with T2* correction and estimation.Non-invasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials.Effect of steatosis on liver signal and enhancement on multiphasic contrast-enhanced magnetic resonance imaging.Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation.
P2860
Q30677112-5536F25F-C3F3-4AEC-9977-06920A104E5BQ30685657-90A7AB3D-7FC0-4B30-967A-91F9E09F79A6Q30702999-7C532D73-0171-4F00-8747-89C96C988155Q31077527-2D60A8FB-7010-4416-8419-96B50711B82BQ33771752-6E17F027-89F4-4D0D-812A-8489658AF28EQ34373792-A1CC1EF6-F55D-48D4-9FBB-B9A6E52761A7Q34575945-772DB938-1CA3-4AD1-9CD8-9777E5416060Q36118818-05EBFC33-B188-4FBF-8962-7871BFD6A191Q36240453-1109A181-E33E-46D1-A4C3-A0E1FC4DA824Q36762955-3DA93792-314C-4463-AF11-AF1405BE15D3Q36762975-978BD5E3-7803-4A26-A410-157A79EBEF52Q37672671-ECD00343-6E9F-4E7B-8FC6-D4891D7B1D83Q38446344-DCA9C83A-B78A-403F-8BCB-30B0395AE882Q38786005-F758F795-32FD-4B36-834D-D58626945778Q39306199-09A1FDAD-02E4-4DF1-A7E7-BD80CB39A41AQ40047726-14A54268-2A1A-4B70-AFD0-2AF667433B9FQ41673841-40DD5BF7-4F7E-4DD7-8418-3E45F4B5A6D5Q46139053-FBBD9017-8459-4D57-8A1F-40983ABAA460Q47436758-43C7B994-6B96-4E20-82FC-02758EECE963Q47692626-A945E4B0-5ED8-48BA-A890-BBBFEFD41137Q47875690-18EC8B81-0D2D-429D-9DAF-D95890C382DAQ48737176-94A3B6CC-4817-4B06-9E67-4E03DFF15618Q49884186-B73F37E1-E4B4-405A-A581-1349D094115DQ53404568-6F5D49B9-289D-4B31-A10D-C08D6705CE6CQ53730590-74BE63D8-CEED-473C-ADB2-2105FA218D60
P2860
Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging.
@en
Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging.
@nl
type
label
Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging.
@en
Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging.
@nl
prefLabel
Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging.
@en
Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging.
@nl
P2093
P2860
P356
P1476
Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging.
@en
P2093
Arian Mashhood
Bernard J Dardzinski
Donald Williams
Eunkyung Kauh
Jonathan Riek
Lisa Clark
Michael S Middleton
Norah J Shire
Radha Railkar
Sabrina Fox-Bosetti
P2860
P304
P356
10.1002/JMRI.23928
P577
2012-11-21T00:00:00Z